Village Farms International, Inc. (VFF) Q2 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call highlights strong international growth, improved margins, and a solid net cash position. Despite a decline in Canadian retail sales, the focus on high-margin products and international expansion is promising. The Q&A reveals management's strategic focus on growth and profitability, with potential upside from U.S. regulatory changes. Positive factors outweigh concerns, suggesting a positive stock price movement.
Key Financial Performance
Consolidated Sales Consolidated sales increased 12% year-over-year to $59.9 million, driven by growth in the Canadian Cannabis segment and the first full quarter of sales from recreational cannabis in the Netherlands.
Net Income from Continuing Operations Net income improved to $9.9 million or $0.09 per share, compared to a net loss of $16.6 million or $0.15 per share in Q2 of last year. This improvement reflects record profitability.
Adjusted EBITDA from Continuing Operations Adjusted EBITDA was $17.1 million or 28.6% of sales, compared to $2.9 million or 5.4% of sales in Q2 of last year. This reflects a record performance for the company.
Canadian Cannabis Gross Margin Gross margin was 39%, up from 26% in Q2 last year, driven by higher-margin international export sales and a focus on higher-margin products in Canada.
International Export Sales International exports increased 690% year-over-year to CAD 16.6 million, driven by demand from Germany, the U.K., and other markets. This growth reflects the success of the international growth strategy.
Canadian Retail Branded Sales Retail branded sales were CAD 34.5 million, 20% lower than Q2 last year, due to a planned reduction in low-margin SKUs. However, gross margin improved due to a focus on higher-margin opportunities.
Net Cash Position The company ended Q2 with a net cash position of $29 million, supported by $40 million in proceeds from the privatization transaction and strong cash flow from operations.
Recreational Cannabis Sales in the Netherlands Sales were $2.5 million in the first full quarter, with an adjusted EBITDA of $1.2 million. The Phase 1 facility reached full operational capacity, and market penetration was 82.5%.
U.S. Cannabis Business Gross Margin Gross margin improved to 63%, benefiting from the internalization of gummy production, despite regulatory challenges in various states.
Canadian Cannabis Adjusted EBITDA Adjusted EBITDA improved 150% year-over-year to CAD 16.5 million, with an adjusted EBITDA margin of 27%, more than double the 12% last year.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Recreational cannabis sales in the Netherlands: First full quarter of sales from Leli Holland operations generated $2.5 million in revenue. Phase 1 facility reached full operational capacity, and Phase 2 facility is expected to quadruple production capacity by Q1 2026.
Hash product launch: New hash offerings to be launched in the Netherlands during Q3 2025.
International cannabis exports: Increased almost 700% year-over-year, driven by demand from Germany, the UK, and other markets. Achieved full-year target of tripling 2024 export sales by mid-2025.
Canadian cannabis market: Retail branded sales realigned towards higher-margin SKUs, resulting in improved gross margins of 39%.
Produce business privatization: Privatized 1/3 of produce assets, generating $40 million in cash proceeds and improving long-term upside potential.
Delta 2 greenhouse conversion: 550,000 square feet of greenhouse space in British Columbia to be converted to cannabis cultivation, adding 40 metric tons of annual production by Q1 2027.
Global cannabis platform transformation: Company has shifted focus to scaling a profitable global cannabis enterprise, leveraging 36 years of expertise in controlled environmental agriculture.
Expansion in cannabis cultivation: Investing in additional capacity in Canada and the Netherlands to meet growing demand and improve profitability.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Market Conditions: The company is not yet seeing expected price increases in the Canadian retail cannabis market despite changing supply dynamics, which could impact profitability.
Regulatory Hurdles: Potential regulatory changes in Germany's telemedicine reforms and Portugal's stringent standards could pose challenges, although the company has not yet been impacted.
Supply Chain Disruptions: The company is reliant on international supply chains for cannabis exports, which could face disruptions or regulatory changes.
Economic Uncertainties: The company’s profitability is heavily reliant on international markets, which could be affected by economic downturns or currency fluctuations.
Strategic Execution Risks: The expansion of the Delta 2 greenhouse and the Phase 2 facility in the Netherlands involves significant capital investment and operational scaling, which could face delays or cost overruns.
Competitive Pressures: The company faces intense competition in the global cannabis market, which could impact market share and pricing power.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Growth and Margin Expansion: Village Farms expects continued revenue growth and margin expansion driven by international cannabis sales, particularly in Germany, the U.K., and other markets. The company anticipates sustaining gross margins at the upper end of the 30%-40% range for the foreseeable future.
International Market Expansion: The company plans to scale its international cannabis operations, with a focus on Germany and the Netherlands. It expects to quadruple production capacity in the Netherlands by Q1 2026 with the completion of its Phase 2 facility.
Canadian Cannabis Expansion: Village Farms announced the conversion of 550,000 square feet of its Delta 2 greenhouse in British Columbia to cannabis cultivation, targeting full production by Q1 2027. This expansion is expected to add 40 metric tons of annual production capacity.
Product Launches: The company plans to launch new cannabis products, including hash offerings in the Netherlands during Q3 2025, and additional products in the second half of the year.
Capital Expenditures: The Delta 2 greenhouse conversion project will require an investment of approximately CAD 10 million, funded through cash on hand and operational cash flows, primarily in 2026.
Market Trends and Regulatory Environment: Village Farms is optimistic about the evolving regulatory environment in international markets, including Germany and Portugal, which supports its growth strategy. The company is also monitoring U.S. cannabis policy developments for future opportunities.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What factors influenced the decision to expand the Delta 2 facility?
A:The decision was influenced by the low investment cost of $7 million, the ability to convert existing assets rather than building new ones, and the flexibility of the facility's design with multiple grow rooms. The company aims to meet demand and avoid oversupply, as they are currently leaving $50 million of revenue on the table.
Q:What were the key drivers for international growth in Q2, and what are the expectations for the second half of the year?
A:Key drivers included strong performance in Germany and the U.K., onboarding new customers, and aligning with growth in international markets. For the second half, the company expects growth to match the first half, with a focus on managing supply and demand.
Q:Can you confirm the segment EBITDA numbers and explain the vendor settlement?
A:The segment EBITDA numbers are: Canadian cannabis - $11.9 million, U.S. cannabis - small positive, Netherlands - $1.2 million, totaling $13.1 million. The vendor settlement of $4.3 million is nonrecurring and pertains to prior losses for continuing assets.
Q:What are the dynamics of the Canadian recreational cannabis market?
A:The market is seeing pricing stabilization in the retail environment, with improving profitability among producers. The company believes the market is starting to see normal supply-demand dynamics and expects the 'cream to rise to the top' among Canadian producers.
Q:What is the outlook for international sales as a percentage of total cannabis revenue by 2026 or 2027?
A:The company expects international sales to potentially maintain a similar mix as in Q2, with growth being hotter overseas than in Canada. Profitability among Canadian LPs will be a key factor in the market dynamics.
Q:Are there any M&A opportunities in the Netherlands, Canada, or the U.S.?
A:The company is focused on organic growth but is open to M&A if it is accretive or strategic. In the U.S., M&A could play a role when the market opens up. In Canada, M&A is unlikely unless tied to technology or other strategic reasons.
Q:What are the implications of U.S. federal rescheduling for the company's Texas greenhouse and overall strategy?
A:Federal rescheduling to Schedule III could open doors for exporting medical marijuana from Canada to the U.S. The company sees Texas as a potential entry point and is prepared to leverage its assets there. They believe the timing of U.S. market opening aligns well with their current strategy.
Q:What are the drivers for Canadian cannabis gross margins, and is there potential for upside?
A:Drivers include SKU mix, customer mix, improved cost base from added unit volume, and continuous improvement efforts. There is potential for upside, especially in newer markets like the U.K., but the company remains cautious due to price compression in Canadian cannabis.
Q:What are the growth drivers for the second half of the year?
A:Growth drivers include ramping up production at Leli, diversifying SKUs, and quadrupling capacity for next year. The company expects to track similar growth to the first half, with constraints on exceeding current levels.
Q:Review of Unclear Management Responses
A:Management avoided directly addressing the question about competitors in the Canadian cannabis market, with the CEO stating, 'if you can't say anything good, don't say anything at all.' Additionally, they did not provide specific guidance for international growth in the second half, citing the need to manage supply and demand.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Delta greenhouse
Director
GACP
Phase facility
Research Division
approach
certification
channel
contribution
conversion
demand dynamic
event
expansion project
flow month
flower preference
gain sale
greenhouse Delta
history
income share
inspection
legacy
level profitability
loss produce
margin end
margin sale
pharmacy
platform
portfolio
privatization transaction
produce asset
profitability cannabis
record level
remainder
sale CAD
sale produce
sale record
segment sale
strength
success margin
world
VFF Transcript
Village Farms International, Inc. (VFF) Q1 2026 Earnings Call Transcript
Positive5-11
The earnings call summary shows strong financial performance with a 27% increase in net sales and a 118% rise in EBITDA. The share repurchase program and increased gross margins are positive indicators. Although cash flow was negative, it is expected to improve. The Q&A section highlighted management's prudent approach to M&A and confidence in market strategy, despite some reluctance to disclose margin details. Overall, the company's performance and strategic decisions suggest a positive outlook for the stock price.
Village Farms International, Inc. (VFF) Q4 2025 Earnings Call Transcript
Positive3-12
The earnings call highlights strong financial performance, including a significant increase in global cannabis sales, net income, and adjusted EBITDA. The share repurchase program indicates confidence in the company's valuation. While there were concerns about the German market, management expects growth to rebound. The strategic expansion and operational efficiencies in Canada and internationally are promising. The lack of specific guidance on cost initiatives is a minor concern, but overall, the positive financial metrics and strategic plans suggest a positive stock price movement.
Village Farms International, Inc. (VFF) Q3 2025 Earnings Call Transcript
Positive11-10
The earnings call highlights strong financial performance, with record net sales, net income, and EBITDA. Growth in Canadian and Netherlands cannabis markets is robust, with significant international expansion plans. Despite some uncertainties in the Q&A, the optimistic guidance, especially in international markets, aligns with a positive outlook. The company's strong financial metrics, optimistic guidance, and strategic market expansion drive a strong positive sentiment, likely resulting in a stock price increase over the next two weeks.
Village Farms International, Inc. (VFF) Q2 2025 Earnings Call Transcript
Positive8-11
The earnings call highlights strong international growth, improved margins, and a solid net cash position. Despite a decline in Canadian retail sales, the focus on high-margin products and international expansion is promising. The Q&A reveals management's strategic focus on growth and profitability, with potential upside from U.S. regulatory changes. Positive factors outweigh concerns, suggesting a positive stock price movement.
VFF Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
